PGEN Precigen, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 5, 2026 10-K/10-Q 八月 4, 2026PGEN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
PGEN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Precigen, Inc. - Common Stock 公司概况(来自维基百科)
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
## History
In 2015, Intrexon purchased Oxitec, a maker of genetically sterile insects, for $160 million. In April 2019, Intrexon formed a subsidiary called Precigen, with a focus on human gene therapy. Precigen went on to win orphan drug status from the FDA for a CAR-T based therapy (investigational drug name PRGN-3006) to treat acute myeloid leukemia. In early 2020, Intrexon adopted the name of its subsidiary, Precigen, and narrowed its focus to human gene editing. With the change in name the CEO of subsidiary Precigen, Helen Sabzevari, took over leadership of the company from Randal J. Kirk.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | PGEN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -6.15年均值 ≈-1.2 | ≈-1.2 | · | · | |
| P/S | 307.45年均值 ≈72.8 | ≈72.8 | 33.5 | 估值过高 | |
| 市净率 (MRQ) | 68.75年均值 ≈26.8 | ≈26.8 | 4.5 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -27.75年均值 ≈25.0 | ≈25.0 | · | · | |
| 股价/自由现金流 (TTM) | -26.05年均值 ≈-11.1 | ≈-11.1 | · | · | |
| 市现率 (TTM) | -26.25年均值 ≈-11.8 | ≈-11.8 | · | · | |
| EV / Revenue (市值/营收) | 306.95年均值 ≈74.0 | ≈74.0 | · | · | |
| 市值/自由现金流 (TTM) | -26.55年均值 ≈-11.3 | ≈-11.3 | · | · | |
| 市净率(有形资产) (MRQ) | 73.05年均值 ≈131.6 | ≈131.6 | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PGEN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Operating Margin (营业利润率) | -1141.1% | · | 12.3% | 顶尖 | |
| EBITDA Margin (息税折旧摊销前利润率) | -1108.1%5年均值 ≈-351.6% | ≈-351.6% | 12.3% | 顶尖 | |
| Pretax Margin (税前利润率) | -2588.2%5年均值 ≈-992.9% | ≈-992.9% | 15.1% | 顶尖 | |
| Net Profit Margin (净利润率) | -2588.2%5年均值 ≈-857.2% | ≈-857.2% | 10.2% | 顶尖 | |
| ROA | -166.7%5年均值 ≈-61.4% | ≈-61.4% | -18.5% | 弱 | |
| ROE | 3159.1%5年均值 ≈1034.3% | ≈1034.3% | -8.4% | 顶尖 | |
| ROIC | -96.9% | · | -31.0% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PGEN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 2.25年均值 ≈2.2 | ≈2.2 | · | · | |
| 流动比率 (MRQ) | 4.65年均值 ≈3.0 | ≈3.0 | 6.5 | 低流动性 | |
| 速动比率 (MRQ) | 3.85年均值 ≈2.5 | ≈2.5 | 6.1 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 2.25年均值 ≈2.1 | ≈2.1 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | PGEN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 146.7%5年均值 ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -28.9%5年均值 ≈-35.3% | ≈-35.3% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -21.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | PGEN | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.15年均值 ≈0.2 | ≈0.2 | 0.1 | 弱 | |
| Receivables Turnover (应收账款周转率) | 4.05年均值 ≈11.0 | ≈11.0 | 7.1 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$60.5K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $0.05 | $-0.01 | 467.6% |
| 2026年3月31日 | 五月 13, 2026 | $-0.02 | $-0.03 | 38.7% |
| 2025年12月31日 | $-0.07 | $-0.09 | 17.6% | |
| 2025年9月30日 | $-1.06 | $-0.10 | -993.9% | |
| 2025年6月30日 | $-0.09 | $-0.08 | -6.8% | |
| 2025年3月31日 | $-0.07 | $-0.08 | 14.2% | |
| 2024年12月31日 | $-0.06 | $-0.06 | -4.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $33M | $38M | $41M | $11M | |
| R&D Expense | $41M | $53M | $49M | · | · | · | · | $405M | $143M | $112M | $147M | $59M | |
| SG&A Expense | $70M | $41M | $40M | · | · | · | · | $138M | $146M | $142M | $109M | $64M | |
| Operating Expenses | $120M | $139M | $106M | · | · | · | · | $666M | $369M | $316M | $320M | $142M | |
| Operating Income | $-111M | $-135M | $-100M | · | · | · | · | $-506M | $-138M | $-125M | $-147M | $-70M | |
| Interest Expense | · | · | · | · | · | · | · | $9M | $611.0K | $861.0K | $1M | $666.0K | |
| Other Non-op | $43.0K | $6M | $627.0K | · | · | · | · | $630.0K | $1M | $2M | $1M | $-168.0K | |
| Pretax Income | $-251M | $-128M | $-96M | $-80M | $-111M | $-105M | $-171M | $-396M | $-78M | $-194M | $-87M | $-86M | |
| Income Tax | $3.0K | $-2M | $-458.0K | $-189.0K | $-160.0K | $-82.0K | $-930.0K | $-15M | $2M | $-4M | $1M | $-103.0K | |
| Net Income | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| EPS (Basic) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| EPS (Diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| Shares (Basic) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| Shares (Diluted) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| EBITDA | $-107M | · | · | $11M | $14M | $18M | $25M | $-472M | $-107M | $-101M | · | $-60M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $8M | $5M | $36M | $52M | $66M | $97M | $68M | $63M | $136M | $27M | |
| Short-term Investments | $68M | $68M | $55M | $51M | $72M | $48M | $9M | $120M | $6M | $175M | $103M | $88M | |
| Receivables | $4M | $926.0K | $902.0K | $978.0K | $1M | $16M | $21M | $21M | $20M | $22M | $25M | $15M | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $7M | $6M | $5M | $7M | $7M | $7M | $4M | |
| Current Assets | $115M | $102M | $69M | $118M | $157M | $149M | $235M | $285M | $154M | $315M | $324M | $175M | |
| PP&E (Net) | $14M | $14M | $7M | $7M | $9M | $35M | $44M | $87M | $113M | $65M | $43M | $38M | |
| PP&E (Gross) | $38M | $37M | $31M | $31M | $30M | $70M | $80M | $136M | $158M | $99M | $69M | $60M | |
| Accum. Depreciation | $24M | $23M | $24M | $23M | $21M | $35M | $36M | $49M | $46M | $34M | $26M | $22M | |
| Goodwill | $15M | $19M | $27M | $37M | $38M | $54M | $54M | $94M | $94M | $157M | $165M | $101M | |
| Intangibles | $3M | $4M | $41M | $44M | $52M | $65M | $68M | $89M | $233M | $226M | $248M | $66M | |
| Other Non-current Assets | $908.0K | $371.0K | $767.0K | $1M | $936.0K | $2M | $1M | $2M | $4M | $4M | $4M | $1M | |
| Total Assets | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Accounts Payable | $12M | $4M | $2M | $4M | $3M | $5M | $6M | $12M | $9M | $8M | $5M | $6M | |
| Short-term Debt | · | · | $0 | $43M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $37M | $22M | $23M | $79M | $35M | $42M | $123M | $62M | $80M | $95M | $76M | $47M | |
| Capital Leases | $4M | $5M | $6M | $7M | $9M | $8M | $10M | $0 | · | · | · | · | |
| Deferred Tax | · | $0 | $2M | $2M | $3M | $3M | $3M | $4M | $16M | $17M | $22M | $0 | |
| Other Non-current Liabilities | $134.0K | $0 | · | · | $50.0K | $100.0K | $0 | $3M | $3M | $4M | $795.0K | $699.0K | |
| Total Liabilities | $135M | $79M | $33M | $90M | $253M | $247M | $384M | $337M | $300M | $380M | $277M | $167M | |
| Long-term Debt | $93M | $0 | · | $43M | $180M | $172M | $218M | $212M | $8M | $8M | $9M | $10M | |
| Total Debt | $93M | · | · | $43M | $183M | $172M | $218M | $212M | $8M | $8M | · | $10M | |
| Paid-in Capital | $2.36B | $2.13B | $2.08B | $2.00B | $2.02B | $1.89B | $1.75B | $1.72B | $1.40B | $1.33B | $1.25B | $843M | |
| Retained Earnings | $-2.34B | $-2.09B | $-1.96B | $-1.87B | $-1.92B | $-1.82B | $-1.65B | $-1.33B | $-848M | $-729M | $-543M | $-458M | |
| AOCI | $7.0K | $12.0K | $-2M | $-3M | $203.0K | $4M | $-27M | $-29M | $-16M | $-36M | $-13M | $-4.0K | |
| Stockholders' Equity | $21M | $39M | $118M | $126M | $107M | $67M | $72M | $363M | $534M | $560M | $694M | $385M | |
| Liabilities + Equity | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Shares Outstanding | 353,910,926 | 292,869,097 | 248,919,096 | 208,150,021 | 206,739,874 | 187,663,207 | 163,274,880 | 160,020,466 | 122,087,040 | 118,688,770 | 116,658,886 | 100,557,932 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $5M | $7M | $11M | $14M | $18M | $25M | $33M | $31M | $25M | $18M | $10M | |
| Stock-based Comp | $11M | $9M | $10M | $10M | $14M | $18M | $19M | $36M | $42M | $42M | $39M | $22M | |
| Deferred Tax | $0 | $-2M | $-479.0K | $-150.0K | $-167.0K | $-156.0K | $-4M | $-21M | $-3M | $-3M | $1M | $0 | |
| Amort. of Intangibles | $1M | $3M | $5M | $5M | $5M | $5M | $8M | $12M | $11M | $15M | $10M | $4M | |
| Other Non-cash | $149M | · | · | $-114M | $9M | $58M | $146M | $337M | $-57M | $67M | · | $30M | |
| Operating Cash Flow | $-88M | $-68M | $-67M | $-65M | $-56M | $-77M | $-136M | $-124M | $-104M | $-49M | $36M | $-20M | |
| CapEx | $2M | $9M | $2M | $5M | $7M | $8M | $38M | $42M | $47M | $32M | $13M | $6M | |
| Investing Cash Flow | $-2M | $-21M | $-3M | $226M | $-75M | $28M | $87M | $-151M | $104M | $-28M | $-259M | $-26M | |
| Debt Issued | $93M | $0 | $0 | · | $0 | $0 | $376.0K | $220M | $325.0K | $547.0K | $81.0K | $268.0K | |
| Net Debt Issued | $93M | · | · | $-155M | $-466.0K | $-490.0K | $-242.0K | $219M | $-194.0K | $-654.0K | · | $-379.0K | |
| Stock Issued | $-355.0K | $31M | $73M | $0 | · | · | · | · | $0 | $0 | $328M | $0 | |
| Net Stock Activity | $-355.0K | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $90M | $111M | $30M | $-155M | $121M | $33M | $8M | $310M | $4M | $12M | $332M | $24M | |
| Net Change in Cash | $717.0K | $22M | $-41M | $5M | $-9M | $-16M | $-42M | $35M | $6M | $-66M | $108M | $-22M | |
| Free Cash Flow | $-90M | · | · | $-70M | $-63M | $-85M | $-174M | $-166M | $-151M | $-88M | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | $-174M | $-151M | $-88M | · | $-27M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1141.1% | · | · | · | · | · | · | · | -59.7% | -65.6% | · | -97.3% | |
| Net Margin | -2588.2% | · | · | 105.2% | -88.7% | -165.3% | · | · | -50.7% | -97.7% | · | -113.8% | |
| Pretax Margin | -2588.2% | · | · | -297.2% | -93.3% | -100.7% | · | · | -56.1% | -101.7% | · | -119.2% | |
| EBITDA Margin | -1108.1% | · | · | 40.0% | 13.2% | 17.0% | · | · | -46.2% | -52.7% | · | -82.8% | |
| ROA | -166.7% | · | · | 9.8% | -27.3% | -44.3% | -55.0% | -65.2% | -13.0% | -19.3% | · | -15.7% | |
| ROE | 3159.1% | · | · | 21.1% | -77.3% | -271.3% | -148.3% | -113.6% | -21.4% | -29.8% | · | -21.8% | |
| ROIC | -96.9% | · | · | · | · | · | · | -84.5% | -24.9% | -21.6% | · | -17.7% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 1.5 | 4.5 | 3.5 | 1.9 | 4.6 | 1.9 | 3.3 | · | 3.7 | |
| Quick Ratio | 2.7 | · | · | 0.7 | 3.9 | 2.8 | 0.8 | 4.0 | 1.2 | 2.7 | · | 2.7 | |
| Debt / Equity | 4.5 | · | · | 0.3 | 1.7 | 2.6 | 3.0 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 4.5 | · | · | 0.0 | 1.7 | 2.6 | 2.6 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | -59.3 | -225.7 | -145.4 | · | -105.0 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.3 | 0.3 | · | · | 0.3 | 0.2 | · | 0.1 | |
| Receivables Turnover | 4.0 | · | · | 23.4 | 5.6 | 5.6 | · | · | 11.2 | 8.2 | · | 9.4 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.06 | · | · | $0.61 | $0.52 | $0.36 | $0.44 | $2.27 | $4.37 | $4.72 | · | $3.83 | |
| Revenue / Share | $0.03 | · | · | $0.13 | $0.53 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.28 | · | · | $-0.32 | $-0.28 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | · | · | $0.02 | $0.21 | $0.28 | $0.40 | $0.64 | $0.56 | $0.53 | · | $0.27 | |
| EPS (TTM) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | $-1.54 | $-1.54 | $-1.54 | $-0.74 | $-0.84 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | -37.0% | -76.9% | 88.6% | -55.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -28.9% | -35.0% | -42.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -21.3% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Net Income TTM | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| Market Cap | $1.48B | · | · | $316M | $767M | $1.91B | $895M | $1.05B | $1.41B | $2.86B | · | $2.65B | |
| Enterprise Value | $1.47B | · | · | $304M | $835M | $1.99B | $1.04B | $1.04B | $1.34B | $2.63B | · | $2.54B | |
| P/E | -3.1 | -2.4 | -3.4 | 10.9 | -7.9 | -10.0 | -2.6 | -4.2 | -7.5 | -15.6 | -40.4 | -31.3 | |
| P/S | 152.8 | · | · | 11.8 | 53.8 | 59.8 | 9.9 | 6.9 | 6.1 | 15.0 | · | 36.8 | |
| P/B | 70.7 | · | · | 2.5 | 7.1 | 28.5 | 12.5 | 2.9 | 2.6 | 5.1 | · | 6.9 | |
| P / Tangible Book | 592.5 | 8.0 | 6.5 | 7.0 | 43.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | -16.8 | · | · | -4.9 | -13.8 | -24.9 | -6.6 | -8.4 | -13.5 | -51.1 | · | -133.2 | |
| P / FCF | -16.5 | · | · | -4.5 | -12.2 | -22.6 | -5.1 | -6.3 | -9.3 | -32.6 | · | -100.9 | |
| EV / EBITDA | -13.7 | · | · | 28.2 | 60.7 | 113.4 | 41.7 | -2.2 | -12.6 | -26.1 | · | -42.7 | |
| EV / FCF | -16.4 | · | · | -4.3 | -13.3 | -23.5 | -6.0 | -6.2 | -8.9 | -30.0 | · | -96.8 | |
| EV / Revenue | 152.3 | · | · | 11.3 | 58.5 | 62.1 | 11.4 | 6.9 | 5.8 | 13.8 | · | 35.3 | |
| Earnings Yield | -32.8% | -42.0% | -29.1% | 9.2% | -12.7% | -10.0% | -38.1% | -23.5% | -13.4% | -6.4% | -2.5% | -3.2% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55M | $23M | · | · | $856.0K | $1M | · | · | · | · | · | · | $2M | $2M | · | $17M | |
| R&D Expense | $7M | $6M | · | · | $11M | $10M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $22M | $21M | · | · | $16M | $12M | · | · | · | · | · | · | · | · | · | · | |
| Operating Expenses | $32M | $29M | · | · | $33M | $24M | · | · | · | · | · | · | · | · | · | · | |
| Operating Income | $23M | $-6M | · | · | $-32M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $16.0K | $290.0K | · | · | $-31.0K | $7.0K | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $20M | $-8M | · | · | $-27M | $-54M | $-20M | $-24M | $-60M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $-87.0K | $12.0K | $-2M | $-29.0K | $-332.0K | $-6.0K | $-65.0K | $-55.0K | $8.0K | $-50.0K | |
| Net Income | $20M | $-8M | $-24M | $-146M | $-27M | $-54M | $-20M | $-24M | $-59M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $87M | |
| EPS (Basic) | $0.06 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| EPS (Diluted) | $0.05 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| Shares (Basic) | 356,893,568 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| Shares (Diluted) | 413,686,865 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| EBITDA | $23M | $-5M | · | · | · | $629.0K | · | · | · | $2M | · | · | · | $2M | · | · |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $7M | $30M | $14M | $14M | $6M | $30M | $25M | $9M | $17M | · | $10M | $17M | $10M | · | $9M | |
| Short-term Investments | $22M | $49M | $68M | $107M | $46M | $74M | $68M | $4M | $10M | $27M | · | $64M | $72M | $94M | · | $62M | |
| Receivables | $72M | $26M | $4M | $580.0K | $327.0K | $751.0K | $926.0K | $479.0K | $511.0K | $872.0K | · | $988.0K | $1M | $2M | · | $1M | |
| Prepaid Expense | $4M | $4M | $3M | $4M | $2M | $3M | $3M | $5M | $3M | $4M | · | $5M | $3M | $4M | · | $6M | |
| Current Assets | $134M | $102M | $115M | $130M | $63M | $85M | $102M | $35M | $24M | $50M | · | $93M | $106M | $138M | · | $163M | |
| PP&E (Net) | $13M | $13M | $14M | $15M | $15M | $15M | $14M | $14M | $13M | $13M | · | $7M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $38M | $38M | $38M | $38M | $37M | $38M | $37M | $36M | $36M | $37M | · | $31M | $31M | $31M | · | $30M | |
| Accum. Depreciation | $25M | $25M | $24M | $23M | $23M | $23M | $23M | $23M | $22M | $25M | · | $24M | $24M | $24M | · | $23M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $19M | $19M | $25M | $25M | $27M | $27M | $37M | $37M | $37M | $37M | $37M | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $39M | · | $40M | $43M | $44M | · | $42M | |
| Other Non-current Assets | $708.0K | $782.0K | $908.0K | $753.0K | $590.0K | $427.0K | $371.0K | $425.0K | $435.0K | $751.0K | · | $797.0K | $949.0K | $1M | · | $871.0K | |
| Total Assets | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Accounts Payable | $5M | $3M | $12M | $6M | $4M | $3M | $4M | $4M | $5M | $5M | · | $2M | $3M | $4M | · | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | · | |
| Current Liabilities | $29M | $21M | $37M | $32M | $23M | $24M | $22M | $21M | $23M | $29M | · | $33M | $31M | $47M | · | $105M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | · | $6M | $7M | $7M | · | $8M | |
| Deferred Tax | · | · | · | · | · | · | · | $89.0K | $77.0K | $2M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $77.0K | $106.0K | $134.0K | $163.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $127M | $118M | $135M | $129M | $108M | $113M | $79M | $28M | $30M | $38M | · | $43M | $41M | $57M | · | $117M | |
| Long-term Debt | $94M | $94M | $93M | $93M | · | · | $0 | · | · | · | · | · | · | · | · | $82M | |
| Total Debt | $94M | $94M | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | $82M | |
| Paid-in Capital | $2.37B | $2.37B | $2.36B | $2.36B | $2.13B | $2.13B | $2.13B | $2.13B | $2.09B | $2.09B | · | $2.08B | $2.08B | $2.08B | · | $2.00B | |
| Retained Earnings | $-2.33B | $-2.35B | $-2.34B | $-2.32B | $-2.17B | $-2.14B | $-2.09B | $-2.07B | $-2.05B | $-1.99B | · | $-1.93B | $-1.91B | $-1.89B | · | $-1.85B | |
| AOCI | $-29.0K | $-17.0K | $7.0K | $24.0K | $11.0K | $12.0K | $12.0K | $13.0K | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-7M | |
| Stockholders' Equity | $44M | $20M | $21M | $42M | $-37M | $-14M | $39M | $55M | $43M | $97M | $118M | $148M | $166M | $184M | $126M | $143M | |
| Liabilities + Equity | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Shares Outstanding | 358,008,798 | 355,903,977 | 353,910,926 | 353,810,556 | 297,846,160 | 295,135,060 | 292,869,097 | 292,869,097 | 252,656,151 | 250,248,808 | 248,919,096 | 256,398,527 | 255,482,753 | 255,482,753 | 208,150,021 | 208,150,021 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $803.0K | $630.0K | $629.0K | $661.0K | $674.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $4M | $3M | $2M | $4M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $-89.0K | $12.0K | $-2M | $-29.0K | $-353.0K | $-13.0K | $-58.0K | $-55.0K | $12.0K | $-50.0K | |
| Amort. of Intangibles | $319.0K | $318.0K | $318.0K | $318.0K | $318.0K | $319.0K | $318.0K | $318.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | $-40M | · | · | · | $35M | · | · | · | $6M | · | · | · | $-441.0K | · | · | |
| Operating Cash Flow | $-18M | $-44M | $-23M | $-29M | $-19M | $-16M | $-8M | $-23M | $-23M | $-14M | $-16M | $-17M | $-16M | $-18M | $-15M | $-24M | |
| CapEx | $392.0K | $258.0K | $18.0K | $389.0K | $966.0K | $622.0K | $1M | $882.0K | $2M | $4M | $1M | $236.0K | $101.0K | $154.0K | $53.0K | $2M | |
| Investing Cash Flow | $27M | $21M | $40M | $-63M | $28M | $-6M | $-65M | $6M | $15M | $24M | $13M | $11M | $24M | $-50M | $11M | $182M | |
| Debt Issued | · | · | $-654.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-29M | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $-355.0K | $-596.0K | $32M | $0 | $0 | $0 | $0 | $-693.0K | $74M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-355.0K | · | · | · | $0 | · | · | · | $74M | · | · | |
| Financing Cash Flow | $-33.0K | $109.0K | $-514.0K | $93M | $-2M | $-679.0K | $78M | $32M | $52.0K | $0 | $0 | $0 | $-15M | $44M | $-39M | $-116M | |
| Net Change in Cash | $9M | $-23M | $16M | $562.0K | $8M | $-23M | $5M | $15M | $-8M | $10M | $-2M | $-7M | $-7M | $-25M | $-43M | $42M | |
| Free Cash Flow | · | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · | · | $-19M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.2% | -25.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1149.9% | -1228.2% | · | 522.5% | |
| Pretax Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1153.6% | -1231.2% | · | -46.0% | |
| EBITDA Margin | 41.2% | -21.1% | · | · | · | · | · | · | · | · | · | · | · | 92.4% | · | · | |
| ROA | 14.8% | -5.9% | · | -114.9% | -30.4% | -41.1% | · | -17.5% | -41.9% | -12.6% | · | -8.8% | -7.7% | -7.9% | · | 27.5% | |
| ROE | 590.6% | -256.8% | · | -301.0% | -833.7% | -130.6% | · | -23.6% | -56.2% | -16.9% | · | -13.6% | -18.3% | -17.6% | · | 63.8% | |
| ROIC | 16.5% | -5.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.8 | · | 4.0 | 2.7 | 3.5 | · | 1.6 | 1.0 | 1.7 | · | 2.8 | 3.4 | 2.9 | · | 1.6 | |
| Quick Ratio | 3.8 | 3.9 | · | 3.8 | 2.6 | 3.4 | · | 1.4 | 0.9 | 1.6 | · | 2.3 | 2.9 | 2.3 | · | 0.7 | |
| Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 0.6 | |
| LT Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.7 | · | · | · | · | · | · | · | · | · | · | 1.3 | 0.1 | · | 1.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $0.06 | · | $0.12 | $-0.12 | $-0.05 | · | $0.19 | $0.17 | $0.39 | · | $0.58 | $0.65 | $0.72 | · | $0.68 | |
| Revenue / Share | $0.13 | $0.07 | · | · | · | · | · | · | · | · | · | · | $0.01 | $0.01 | · | $0.08 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.06 | · | · | · | $-0.06 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.05 | $0.02 | · | $0.04 | $0.05 | $0.02 | · | $0.08 | $0.04 | $0.07 | · | $0.04 | $0.06 | $0.04 | · | $0.04 | |
| EPS (TTM) | $-1.07 | $-1.21 | · | $-1.38 | $-0.41 | $-0.55 | · | $-0.55 | $-0.54 | $-0.39 | · | $-0.37 | $0.15 | $0.14 | · | $0.12 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-158M | $-204M | · | $-247M | $-124M | $-157M | · | $-140M | $-135M | $-97M | · | $-85M | $22M | $25M | · | $25M | |
| Market Cap | $2.04B | $1.38B | · | $1.16B | $423M | $440M | · | $278M | $399M | $363M | · | $364M | $294M | $271M | · | $441M | |
| Enterprise Value | $2.10B | $1.41B | · | · | · | · | · | · | · | · | · | $290M | $205M | $181M | · | $452M | |
| P/E | -5.3 | -3.2 | · | -2.4 | -3.5 | -2.7 | · | -1.7 | -2.9 | -3.7 | · | -3.8 | 7.7 | 7.6 | · | 17.7 | |
| P/B | 46.8 | 68.1 | · | 27.8 | -11.5 | -31.3 | · | 5.0 | 9.2 | 3.7 | · | 2.5 | 1.8 | 1.5 | · | 3.1 | |
| P / Tangible Book | 79.1 | 643.9 | · | 50.3 | · | · | · | 10.8 | 30.3 | 11.4 | · | 5.2 | 3.4 | 2.6 | · | 7.0 | |
| P / Cash Flow | · | -31.4 | · | · | · | -26.9 | · | · | · | -25.8 | · | · | · | -14.7 | · | · | |
| Earnings Yield | -18.8% | -31.3% | · | -41.9% | -28.9% | -36.9% | · | -57.9% | -34.2% | -26.9% | · | -26.1% | 13.0% | 13.2% | · | 5.7% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $10M | $4M | $6M | $27M | $14M |
| 营业利润率 % | -1141.1% | · | · | · | · |
| 净收入 | $-251M | $-126M | $-96M | $28M | $-92M |
| 稀释后每股收益 (EPS) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 4.5 | · | · | 0.3 | 1.7 |
| 流动比率 | 3.1 | · | · | 1.5 | 4.5 |
| 速动比率 | 2.7 | · | · | 0.7 | 3.9 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-90M | · | · | $-70M | $-63M |
机构持有人 (13F) 235 家申报者 · $868.3M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 40 (-10 与上一季度对比) | 26 (+10 与上一季度对比) | 89 (+18 与上一季度对比) | 46 (-3 与上一季度对比) | +8.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Patient Capital Management, LLC | $108510760 | 19036976 | 12.50% | 股份 |
| BlackRock, Inc. | $97737450 | 17146921 | 11.26% | 股份 |
| STATE STREET CORP | $68414051 | 12002465 | 7.88% | 股份 |
| Diametric Capital, LP | $52838578 | 9269926 | 6.09% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $45065112 | 7906160 | 5.19% | 股份 |
| VANGUARD GROUP INC | $43804109 | 10479452 | 5.04% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $36579750 | 6417500 | 4.21% | 股份 |
| Boxer Capital Management, LLC | $29355000 | 5150000 | 3.38% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $28612911 | 5019028 | 3.30% | 股份 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $22982189 | 4031963 | 2.65% | 股份 |
| MORGAN STANLEY | $19776885 | 3469628 | 2.28% | 股份 |
| Occam Crest Management LP | $19652378 | 3605941 | 2.26% | 股份 |
| GOLDMAN SACHS GROUP INC | $19416797 | 3406456 | 2.24% | 股份 |
| FMR LLC | $14650046 | 2570183 | 1.69% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12603680 | 2211172 | 1.45% | 股份 |
| FIRST TRUST ADVISORS LP | $11483556 | 2014659 | 1.32% | 股份 |
| BANK OF AMERICA CORP /DE/ | $10535960 | 1848414 | 1.21% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10192940 | 1788235 | 1.17% | 股份 |
| NORTHERN TRUST CORP | $10142467 | 1779380 | 1.17% | 股份 |
| Caption Management, LLC | $9690000 | 1700000 | 1.12% | 卖出期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8640362 | 1515853 | 1.00% | 股份 |
| Diametric Capital, LP | $8048400 | 1412000 | 0.93% | 买入期权 |
| Woodline Partners LP | $7991087 | 1401945 | 0.92% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $7386904 | 1295948 | 0.85% | 股份 |
| Point72 Asset Management, L.P. | $7220070 | 1266679 | 0.83% | 股份 |
| FRANKLIN RESOURCES INC | $5846205 | 1025650 | 0.67% | 股份 |
| BARCLAYS PLC | $5308799 | 931368 | 0.61% | 股份 |
| Caption Management, LLC | $5130000 | 900000 | 0.59% | 股份 |
| JPMORGAN CHASE & CO | $5077625 | 849298 | 0.58% | 股份 |
| PRELUDE CAPITAL MANAGEMENT, LLC | $5028922 | 882267 | 0.58% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5023410 | 881300 | 0.58% | 买入期权 |
| CITADEL ADVISORS LLC | $4676217 | 820389 | 0.54% | 股份 |
| UBS Group AG | $4438949 | 778763 | 0.51% | 股份 |
| CITIGROUP INC | $4131856 | 724887 | 0.48% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4025876 | 706294 | 0.46% | 股份 |
| Nuveen, LLC | $4006154 | 702834 | 0.46% | 股份 |
| GMT Capital Corp | $3812331 | 668830 | 0.44% | 股份 |
| LexAurum Advisors, LLC | $3638954 | 638413 | 0.42% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $3450210 | 605300 | 0.40% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3430511 | 601844 | 0.40% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $3164811 | 555230 | 0.36% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $2943091 | 516332 | 0.34% | 股份 |
| CIBC Bancorp USA Inc. | $2849498 | 499912 | 0.33% | 股份 |
| Lansing Street Advisors | $2823905 | 495422 | 0.33% | 股份 |
| Bank of New York Mellon Corp | $2704635 | 474497 | 0.31% | 股份 |
| Swiss National Bank | $2226420 | 390600 | 0.26% | 股份 |
| Cetera Investment Advisers | $2209947 | 387710 | 0.25% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $2175222 | 381618 | 0.25% | 股份 |
| PEAK6 LLC | $2100450 | 368500 | 0.24% | 买入期权 |
| Persistent Asset Partners Ltd | $2027872 | 355767 | 0.23% | 股份 |
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RANDAL J. KIRK, R.J. KIRK DECLARATION OF TRUST, THIRD SECURITY, LLC ×21 申报 | 2026年3月31日 | 35.90% | 修订 | · | SEC |
| 2020年1月6日 | · | 初始申报 | · | SEC | |
| 2017年10月23日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 40 位内幕人士 · 16 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Helen Sabzevari | President and CEO | 2026年8月23日 M | 3779521 | 0 | 2 | $-2562794 |
| Harry Thomasian Jr. | Chief Financial Officer | 2026年9月23日 M | 311914 | 0 | 4 | $-1901756 |
| Rick L. Sterling | Chief Financial Officer | 2021年1月4日 M | 340020 | 0 | 0 | $0 |
| Rutul R Shah | Chief Operating Officer | 2026年8月25日 M | 468865 | 0 | 6 | $-1256398 |
| Thomas Bostick | Chief Operating Officer | 2020年1月4日 M | 74280 | 0 | 0 | $0 |
| Phil Tennant | Chief Commercial Officer | 2026年8月25日 M | 141992 | 0 | 2 | $-725731 |
| Donald P. Lehr | Chief Legal Officer | 2026年8月23日 M | 758181 | 0 | 1 | $-127011 |
| Jeffrey Thomas Perez | SVP, IP Affairs | 2024年8月9日 P | 743097 | 0 | 0 | $0 |
| Bradford D. Osborne | VP, Finance and Accounting | 2021年4月21日 A | · | 0 | 0 | $0 |
| Thomas D. Reed | Chief Science Officer | 2020年1月4日 M | 148888 | 0 | 0 | $0 |
| Robert F. Walsh III | SVP, Energy & Fine Chem. | 2019年6月30日 M | 28816 | 0 | 0 | $0 |
| Nir Nimrodi | Chief Business Officer | 2019年1月4日 A | 19482 | 0 | 0 | $0 |
| Joel D Liffman | SVP, Finance | 2019年1月4日 A | 99315 | 0 | 0 | $0 |
| Kelly Huang | SVP-Consumer Sector | 2014年5月9日 P | 3200 | 0 | 0 | $0 |
| Thomas R. Kasser | SVP--Food Sector | 2014年5月9日 P | 15000 | 0 | 0 | $0 |
| Darryl Webster | SVP--Intellectual Property | 2014年3月20日 A | 9132 | 0 | 0 | $0 |
| Jeffrey B Kindler | 董事 | 2026年8月26日 S | 17100 | 0 | 2 | $-2231145 |
| Nancy H Agee | 董事 | 2026年8月21日 P | 309187 | 1 | 0 | $24662 |
| RANDAL J. KIRK | 董事 | 2026年3月30日 S | 12262741 | 0 | 25 | $-35984076 |
| Vinita D Gupta | 董事 | 2026年3月13日 M | 666027 | 0 | 0 | $0 |
| Steven Frank | 董事 | 2026年3月13日 M | 1226391 | 0 | 0 | $0 |
| James S Turley | 董事 | 2026年3月13日 M | 685417 | 0 | 0 | $0 |
| Cesar L Alvarez | 董事 | 2026年3月13日 M | 782909 | 0 | 0 | $0 |
| Fred Hassan | 董事 | 2026年3月13日 M | 1243239 | 0 | 0 | $0 |
| Dean J Mitchell | 董事 | 2024年3月14日 A | 503183 | 0 | 0 | $0 |
| Robert B Shapiro | 董事 | 2023年3月9日 A | 329656 | 0 | 0 | $0 |
| Trading S.A. Ares | 10% 所有者 | 2021年10月13日 S | 20647152 | 0 | 0 | $0 |
| Andrew J. Last | · | 2017年11月13日 P | 4000 | 0 | 0 | $0 |
| Geno J Germano | · | 2016年9月22日 A | · | 0 | 0 | $0 |
| Suma Krishnan | · | 2016年1月29日 M | 56657 | 0 | 0 | $0 |
| Krish S Krishnan | · | 2016年1月29日 M | 56657 | 0 | 0 | $0 |
| Ena Chan Cratsenburg | · | 2016年1月7日 A | · | 0 | 0 | $0 |
| INTREXON CORP | · | 2016年1月7日 A | · | 0 | 0 | $0 |
| Joseph L Vaillancourt | · | 2015年10月19日 A | · | 0 | 0 | $0 |
| Corey Huck | · | 2015年10月12日 A | · | 0 | 0 | $0 |
| Samuel Broder | · | 2015年7月21日 A | · | 0 | 0 | $0 |
| Jack A Bobo | · | 2015年7月20日 A | · | 0 | 0 | $0 |
| Olivier Roger Jarry | · | 2015年6月11日 A | · | 0 | 0 | $0 |
| Gregory Ian Frost | · | 2015年5月28日 M | 300000 | 0 | 0 | $0 |
| HORNER LARRY D /FA | · | 2015年3月12日 A | 68507 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 29 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.94% | 304977 NS | 2026年7月31日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.74% | 1539558 NS | 2026年7月31日 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.62% | 17299 SH | 2026年10月2日 | 每日 |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.40% | 198876 SH | 2026年10月2日 | 每日 |
| FYX · First Trust Exchange-Traded Alpha... | 0.35% | 765206 NS | 2026年7月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.31% | 240763 NS | 2026年7月31日 | N-PORT |
| IWC · iShares Trust | 0.30% | 655175 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.20% | 25265 SH | 2026年10月2日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.15% | 139467 NS | 2026年7月31日 | N-PORT |
| PWS · Pacer Funds Trust | 0.09% | 3289 NS | 2026年7月31日 | N-PORT |
| IWO · iShares Trust | 0.08% | 1802964 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.08% | 292277 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.08% | 1205825 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 206995 SH | 2026年8月19日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.04% | 49171 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.04% | 4946547 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.04% | 92222 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 1111545 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.02% | 585833 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 92500 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.02% | 22110 SH | 2026年9月11日 | 每日 |
| WSML · iShares Trust | 0.01% | 10765 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 2042450 SH | 2026年8月19日 | 每日 |
| IWV · iShares Trust | 0.00% | 62200 SH | 2026年9月9日 | 每日 |
| ITOT · iShares Trust | 0.00% | 286766 SH | 2026年9月11日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5690796 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 14522 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 8008 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 25549 SH | 2026年9月11日 | 每日 |
PGEN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
3 位分析师 · 2026-10-01平均目标 $13.65 +63.2%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。